Skip to main content

Drugs

Ausgabe 1/2014

Inhalt (13 Artikel)

Current Opinion

Opioids for Chronic Refractory Breathlessness: Right Patient, Right Route?

David C. Currow, Magnus Ekstrom, Amy P. Abernethy

Open Access Review Article

A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program

Miguel O’Ryan, Jeffrey Stoddard, Daniela Toneatto, James Wassil, Peter M. Dull

Review Article

Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli

George G. Zhanel, Phillip Chung, Heather Adam, Sheryl Zelenitsky, Andrew Denisuik, Frank Schweizer, Philippe R. S. Lagacé-Wiens, Ethan Rubinstein, Alfred S. Gin, Andrew Walkty, Daryl J. Hoban, Joseph P. Lynch 3rd, James A. Karlowsky

Adis Drug Evaluation

Miglustat: A Review of Its Use in Niemann-Pick Disease Type C

Katherine A. Lyseng-Williamson

R&D Insight Report

Macitentan: First Global Approval

Trina Patel, Kate McKeage

R&D Insight Report

Vortioxetine: First Global Approval

Andrew Gibb, Emma D. Deeks

R&D Insight Report

Obinutuzumab: First Global Approval

Fiona Cameron, Paul L. McCormack

Erratum

Erratum to: Should Mild COPD Be Treated? Evidence for Early Pharmacological Intervention

Amany F. Elbehairy, Katherine A. Webb, J. Alberto Neder, Denis E. O’Donnell

Aktuelle Ausgaben